Purdue Pharma and U.S. States Reach $6 Billion Opioid Settlement
The Sackler family agreed to pay as much as $6 billion
US States, Purdue Pharma Reach New Settlement in OxyContin Lawsuit 
Sackler family to pay up to $6 billion in exchange for protection from civil suits
Sacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis
The Sackler family members who own Purdue Pharma have agreed to a $6 billion bankruptcy settlement over the company's role in the opioid crisis.
Sacklers and Purdue Pharma Reach New Deal With States Over Opioids
The agreement brought holdout states on board, and would settle thousands of lawsuits over the company’s and family’s roles in the opioid epidemic. The Sacklers agreed to pay an extra $1 billion.
Big opioid settlement
Purdue Pharma reached a nationwide settlement Thursday over its role in the opioid crisis, with the Sackler family members who own the company boosting their cash contribution to as much as $6 billion in a deal intended to staunch a flood of lawsuits facing the maker of OxyContin.
Judge gives more time for Purdue Pharma settlement talks
Members of the Sackler family who own OxyContin maker Purdue Pharma will get protection from lawsuits for another three weeks, a judge said Wednesday, buying more time to work out a settlement of thousands of legal claims against the company over the toll of opioids.
Purdue Pharma, U.S. states agree to new opioid settlement
Purdue Pharma reached a nationwide settlement Thursday over its role in the opioid crisis, with the Sackler family members who own the company boosting their cash contribution to as much as US$6 billion in a deal intended to staunch a flood of lawsuits facing the maker of OxyContin.
last updated on 25 Mar 18:39